A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 32,511 shares of ZTS stock, worth $5.85 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
32,511
Previous 31,605 2.87%
Holding current value
$5.85 Million
Previous $5.35 Million 5.4%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$145.54 - $178.83 $131,859 - $162,019
906 Added 2.87%
32,511 $5.64 Million
Q1 2024

Apr 23, 2024

BUY
$165.67 - $199.94 $435,049 - $525,042
2,626 Added 9.06%
31,605 $5.35 Million
Q4 2023

Feb 01, 2024

SELL
$151.44 - $200.09 $48,157 - $63,628
-318 Reduced 1.09%
28,979 $5.72 Million
Q3 2023

Nov 03, 2023

SELL
$167.14 - $192.77 $4,847 - $5,590
-29 Reduced 0.1%
29,297 $5.1 Million
Q2 2023

Aug 01, 2023

BUY
$160.94 - $186.23 $140,178 - $162,206
871 Added 3.06%
29,326 $5.05 Million
Q1 2023

May 02, 2023

BUY
$145.48 - $175.02 $40,734 - $49,005
280 Added 0.99%
28,455 $4.74 Million
Q4 2022

Mar 02, 2023

SELL
$131.14 - $157.47 $8,524 - $10,235
-65 Reduced 0.23%
28,175 $4.13 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $44,587 - $53,539
-340 Reduced 1.19%
28,240 $4.71 Million
Q2 2022

Jul 26, 2022

BUY
$155.97 - $200.09 $169,071 - $216,897
1,084 Added 3.94%
28,580 $4.91 Million
Q1 2022

Apr 13, 2022

BUY
$181.39 - $234.03 $117,540 - $151,651
648 Added 2.41%
27,496 $5.19 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $72,827 - $92,883
376 Added 1.42%
26,848 $6.55 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $36,722 - $40,679
194 Added 0.74%
26,472 $5.14 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $215,297 - $259,614
1,381 Added 5.55%
26,278 $4.9 Million
Q1 2021

Apr 14, 2021

BUY
$144.0 - $169.39 $202,896 - $238,670
1,409 Added 6.0%
24,897 $3.92 Million
Q4 2020

Jan 14, 2021

BUY
$157.07 - $174.35 $24,031 - $26,675
153 Added 0.66%
23,488 $3.89 Million
Q3 2020

Oct 15, 2020

BUY
$137.1 - $165.37 $143,406 - $172,977
1,046 Added 4.69%
23,335 $3.86 Million
Q2 2020

Jul 30, 2020

BUY
$111.92 - $142.53 $545,386 - $694,548
4,873 Added 27.98%
22,289 $3.05 Million
Q1 2020

Apr 15, 2020

BUY
$92.66 - $144.94 $84,783 - $132,620
915 Added 5.55%
17,416 $2.05 Million
Q4 2019

Jan 22, 2020

BUY
$116.25 - $133.25 $407,107 - $466,641
3,502 Added 26.94%
16,501 $2.18 Million
Q3 2019

Nov 05, 2019

SELL
$112.57 - $128.43 $17,898 - $20,420
-159 Reduced 1.21%
12,999 $1.62 Million
Q2 2019

Aug 09, 2019

BUY
$97.98 - $114.28 $412,201 - $480,775
4,207 Added 47.0%
13,158 $1.49 Million
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $168,311 - $202,258
2,123 Added 31.09%
8,951 $766,000
Q3 2018

Oct 31, 2018

BUY
$83.5 - $93.23 $21,292 - $23,773
255 Added 3.88%
6,828 $625,000
Q2 2018

Aug 07, 2018

BUY
$79.9 - $89.2 $31,960 - $35,680
400 Added 6.48%
6,573 $560,000
Q4 2017

Feb 08, 2018

BUY
$63.24 - $72.8 $59,129 - $68,068
935 Added 17.85%
6,173 $445,000
Q3 2017

Oct 27, 2017

BUY
$59.73 - $65.4 $154,402 - $169,059
2,585 Added 97.44%
5,238 $334,000
Q2 2017

Aug 07, 2017

BUY
N/A
2,653
2,653 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.